For instance, one criterion is the presence of a breast tumour before the age of 60 that is estrogen and progesterone receptor negative with no overexpression of human epidermal growth factor receptor 2 (HER2), referred to as triple negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.